{"name":"Egetis Therapeutics","slug":"egetis-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQejktUnhTZmwwcnJ4RGppeFU3RkowVUFGQ3UwWnJSUUFuSV9BMFdpR3QxMkwxaGlRVWVhRkxfY3piSFdjMGl0dU9qeGdJbzEtOGlHSlFFbExsU1FBdm5tRzNtQkd0V1lQSG4ybDM3S1pOM3pRbU9RMXlITS1vLXl3ektRWk82Y0FzYTRRZWlhTF9uNkoxX3IwbHdRaTdYbWVLeFFHRUYyQzczd0NPS3AxejRvbUh0bUpmZ2pQeHNvaC0teHNxcmZoUFhsUTU0NHhpRktnUXZuQVZVem1lMmM1MHpiajVtUQ?oc=5","date":"2026-03-24","type":"pipeline","source":"TipRanks","summary":"Egetis Therapeutics Highlights Rare Disease Focus and Commercialization Plans in 2025 Annual Report - TipRanks","headline":"Egetis Therapeutics Highlights Rare Disease Focus and Commercialization Plans in 2025 Annual Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWVpRWGpuSW1Xb3ZwcWk2eURvZWVwUmVDRTBVbW1OZDliYTlxSHBBOTczZVlwcWt6TVd0Zlh0UExXWnlHM1l4cWUwN2c4Yk96TlJSTUlIdkxudzgyelU2emFlTUdTdmJmb1ZhSTF4YmFzR043cFg2ZWpac29TZHl0V1VucVgzZ1AxZjJicm5hQXYwb01LZnNQZU5tQ1hsUkRSeEU2OEVKTU54MjdlbWkzX29PaWdXWmE5bEphM2ZIb0Vadw?oc=5","date":"2026-02-24","type":"pipeline","source":"TradingView","summary":"Egetis Therapeutics to Present at Upcoming Investor Events - TradingView","headline":"Egetis Therapeutics to Present at Upcoming Investor Events","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVUg1eUttOXdJcHVpWlY4RUNUSnpwWEFBYzR1VkNPTkdzdjVmOTNjbWhRVmJVcFVFSnJLV1ZKb005Z1VHUzEzRnF2Y18xem9OU0JGTldFWHEwY0NyZUt3LWh1UVFfSHM2MUgzZ0FjdkRGVGxrS1htZ0Zmd3UzSUVPV2UtVnRsVUJkRWFScEZWbU16MVdSU0JMZU8xTDdxLXZTajlTcnFkMFl2OV9EY1Q5Mlg4Njk0Sy1MQ2Jncmt1cXB1UEVyc0hidFg4WkZtV0V4V0E?oc=5","date":"2026-02-04","type":"regulatory","source":"Investing.com","summary":"Egetis Therapeutics eligible for FDA priority review voucher upon approval - Investing.com","headline":"Egetis Therapeutics eligible for FDA priority review voucher upon approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNQks5OVhYc0UxZEdacVVldzhGNjlVYmhzYUdCdE83X0xSWndKZWJwLTVscjJ3eHdYTkdXU1RMcXVYRTdqc2pGaUlpcnRpLXpQSm8tQUFVZjJSajdYbWotSHEyckJWMjVPTXhwQ0dqenpKTGh3YnV4ZEc0ZVhaRVlUblhld2REUFFkckljbUVVMDRmQVptUVpoRmRzSHlZajFxNzR3REZ5ckc?oc=5","date":"2025-12-19","type":"pipeline","source":"European Biotechnology Magazine","summary":"Egetis Therapeutics AB submits rolling NDA for tiratricol - European Biotechnology Magazine","headline":"Egetis Therapeutics AB submits rolling NDA for tiratricol","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-30","type":"earnings","source":"simplywall.st","summary":"Egetis Therapeutics AB (publ)'s (STO:EGTX) Profit Outlook - simplywall.st","headline":"Egetis Therapeutics AB (publ)'s (STO:EGTX) Profit Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNem1ibXBscHdVYlFUT1RVLXNURDJrOGxPMGNuOEZFRVR3Mzk0RFJmM2RHQlRuTm9nNElZWlRXWThWWWxqeHhFM2lEd3JSRzczWTJCanNzZDU4M2tHekZRTlkyTE9TNGIxUVBNZnFHaEdNemdUV0szNndvWjlOLXh2NQ?oc=5","date":"2025-10-03","type":"regulatory","source":"Endpoints News","summary":"FDA OKs Zepzelca-Tecentriq combo; CSL Vifor’s layoffs - Endpoints News","headline":"FDA OKs Zepzelca-Tecentriq combo; CSL Vifor’s layoffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPOHZGRW5JUktsd3RhaUhNcUc1WlhYUWItQnpodWd6Z1FuLWE1S19OYWJEa2J1eVg3V3d6ZEZWUHlyZURJZDIza0hOOTBqVnBQZjBpTmxUMTJaRXFhOTVGWWYxSURzQngxT3NSTEVPdVhkVXZUZWk5NWI4S0RjOTZvdWtoMmNyaTV3ekhvZ1BEc0pUcjNOM3BoR1NCSXlvb0hkOXVqREpUeTl1N2IzY000ZkNHTzdRQzFFMFUzazlMYU44YUJHbkt6cG8tUUxCM0ROWEplSA?oc=5","date":"2025-06-05","type":"trial","source":"Cision News","summary":"TIRmed Pharma appoints Peder Walberg to the board – strengthens position ahead of clinical phase - Cision News","headline":"TIRmed Pharma appoints Peder Walberg to the board – strengthens position ahead of clinical phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxObmZ0WE11T0NITDVoaXVMYWxpcnBLcVpwcnU4dlZXOWY4T09WZmFDalpOcXVRU3l5YmFHRll1WlBkQWxlOThkOUdpcm9xM1g3UllIR3hySWxIS3NCZVkxN3BPdXVTNk5ZT3NqS0YwTzFsem82TE1ITkRENTdVLWxJbHNMRDFERldqSkFZT3Q2TVViZ3h4dkprcUlib0Y0UmVqY0VZWVFFbE1WLWpRakliaTA3cmJJN3lEMlRVam96dl9CTnIyWDVDdTR1TjJXZ2tiZWVHTw?oc=5","date":"2025-02-14","type":"pipeline","source":"Citeline News & Insights","summary":"Egetis Eager To Launch Ultra Rare Disease Drug Emcitate - Citeline News & Insights","headline":"Egetis Eager To Launch Ultra Rare Disease Drug Emcitate - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQYjVZbEFjUE11VUp0Sl9OcTJWTW0yYUhLSzFkTU5kMjFaaGZrSUQ5UmpOUXd2OGxaYmFLbWdEaW1UR2w2cFhKQUp3MFhnZDdYWGJMOFJrc1RGMXloS29VdzJMcms2bEFvWW9IdUFnY2ItRTFnbnhkN1BDNU9fNVowQ0tJdXpkNnRQeGgzZ0dGcW1icDc2X19rckJIZlpYQVFFbUZVb2RQek9EVXNqTW5NXw?oc=5","date":"2023-03-31","type":"deal","source":"Fierce Biotech","summary":"What M&A slowdown? Buyers circle GreenLight Biosciences, Egetis Therapeutics - Fierce Biotech","headline":"What M&A slowdown? Buyers circle GreenLight Biosciences, Egetis Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE52V09ZNjF6bGV3bjVBMkdkOVlFUFhGMXVIWmVyOEpGazZOOG5EUl9RNVZtdlZTV3hKX3RQb2wtOExUZnE0eGhqdzRTZTZHcEY5RlFTcWFmZWZJOTdr?oc=5","date":"2020-12-19","type":"pipeline","source":"TradingView","summary":"EGTX Stock Price and Chart — OMXSTO:EGTX - TradingView","headline":"EGTX Stock Price and Chart — OMXSTO:EGTX","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}